Neurology

We are researching new therapies against Alzheimer's disease, multiple sclerosis and Parkinson's disease and are committed to the treatment of Parkinson's disease in its advanced stages. Dementia cure research is crucial to us.

An overview of Neurology

Parkinson's disease

After Alzheimer's, Parkinson's disease is the second most common neurodegenerative disease worldwide. It is a chronic disease of the nerve cells in the part of the brain that controls movement. Typical symptoms of Parkinson's disease are muscle tremors, slower movement, stiffening of the muscles, and gait or balance disorders. Parkinson's disease has a major impact on quality of life. Far more than 220,000 people are affected in Germany, with an additional 15-20,000 each year.

Parkinson's cannot be cured, but Parkinson's therapy aims primarily to alleviate symptoms and accompanying symptoms. In the advanced stages of the disease or after prolonged drug treatment, the effect of the previous therapy may wane or there may be fluctuations in effectiveness. If this is the case, adequate continuous therapy may be indicated in order to positively influence the quality of life of those affected.

Alzheimer's disease

It is estimated that around 50 million people worldwide live with dementia. The most serious symptom is a massively impaired ability to think and remember, which is not related to the normal aging process. Alzheimer's is the most common form of dementia; around 60 to 70 percent of all those affected live with it.

Well over 100 years after its discovery, the neurodegenerative disease still puzzles scientists. Alzheimer's disease cannot be prevented or cured. With Alzheimer's therapy currently available, doctors can temporarily slow the worsening of symptoms. This can improve the quality of life of patients and the relatives who care for them.

We are working with the world's leading Alzheimer's researchers and are looking for ways to treat Alzheimer's and stop the disease at an early stage.

Multiple sclerosis

Multiple sclerosis (MS) is a progressive chronic inflammatory disease of the central nervous system. The typical age of onset is between 20 and 40 years. In MS, the immune system attacks a protein called myelin, which forms a protective layer around nerve fibers. If the protein is damaged, the nerve cells have difficulty communicating, so that stimuli are transmitted poorly or not at all. Multiple sclerosis is also known as the "disease of many faces" because the symptoms can be so different. We are working on treatment options that promote nerve protection and nerve cell regeneration.

Register to explore our entire offering of neuroscience content

Stay up-to-date with the latest neuroscience news and information plus access to our full range of neuroscience content; including educational resources, specialist articles, expert interviews and more.